Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection.

[1]  R. van Furth,et al.  QUANTITATIVE STUDY ON THE PRODUCTION AND KINETICS OF MONONUCLEAR PHAGOCYTES DURING AN ACUTE INFLAMMATORY REACTION , 1973, The Journal of experimental medicine.

[2]  J. Sypek,et al.  Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic. , 1984, Journal of immunology.

[3]  R T Tranquillo,et al.  A stochastic model for leukocyte random motility and chemotaxis based on receptor binding fluctuations , 1988, The Journal of cell biology.

[4]  M. Goebeler,et al.  Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. , 1993, Journal of immunology.

[5]  P. Ewald.  Evolution of Infectious Disease , 1993 .

[6]  A. Perelson,et al.  Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.

[7]  J. Louis,et al.  Leishmania major interferes with antigen presentation by infected macrophages. , 1993, Journal of immunology.

[8]  T. J. Mitchell,et al.  Exploratory designs for computational experiments , 1995 .

[9]  Yadollah Mehrabi,et al.  LIKELIHOOD-BASED METHODS FOR BIAS REDUCTION IN LIMITING DILUTION ASSAYS , 1995 .

[10]  I. Charles,et al.  Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.

[11]  A. C. Rencher.  Methods of multivariate analysis , 1995 .

[12]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[13]  G. Vallortigara,et al.  Right-pawedness in toads , 1996, Nature.

[14]  C. Haslett,et al.  In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. , 1996, Journal of immunology.

[15]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[16]  R. Badolato,et al.  Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. , 1996, Experimental parasitology.

[17]  R T Damian,et al.  Parasite immune evasion and exploitation: reflections and projections , 1997, Parasitology.

[18]  Sylvia Richardson,et al.  Markov Chain Monte Carlo in Practice , 1997 .

[19]  A. Haman,et al.  Crucial Role of the Residue R280 at the F′–G′ Loop of the Human Granulocyte/Macrophage Colony-stimulating Factor Receptor α Chain for Ligand Recognition , 1997, The Journal of experimental medicine.

[20]  Stephanie Forrest,et al.  Infect Recognize Destroy , 1996 .

[21]  Gross,et al.  Down‐regulation of MHC class II molecules and inability to up‐regulate class I molecules in murine macrophages after infection with Toxoplasma gondii , 1998, Clinical and experimental immunology.

[22]  Y. Belkaid,et al.  A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity , 2000, The Journal of Immunology.

[23]  G. Modi,et al.  Evolution of Lesion Formation, Parasitic Load, Immune Response, and Reservoir Potential in C57BL/6 Mice following High- and Low-Dose Challenge with Leishmania major , 2000, Infection and Immunity.

[24]  C. Bogdan,et al.  Fibroblasts as Host Cells in Latent Leishmaniosis , 2000, The Journal of experimental medicine.

[25]  G An,et al.  Agent-based computer simulation and sirs: building a bridge between basic science and clinical trials. , 2001, Shock.

[26]  A. O'Hagan,et al.  Bayesian calibration of computer models , 2001 .

[27]  J. Banchereau,et al.  Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells , 2001, The Journal of experimental medicine.

[28]  F Castiglione,et al.  Selection of escape mutants from immune recognition during HIV infection , 2002, Immunology and cell biology.

[29]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[30]  A. Caton,et al.  Cutting Edge: Self-Peptides Drive the Peripheral Expansion of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.

[31]  A. Palucka,et al.  TNF Skews Monocyte Differentiation from Macrophages to Dendritic Cells 1 , 2003, The Journal of Immunology.

[32]  Kwang-Poo Chang,et al.  Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. , 2003, Acta tropica.

[33]  Thomas J. Santner,et al.  The Design and Analysis of Computer Experiments , 2003, Springer Series in Statistics.

[34]  Syamal Roy,et al.  Role of chemokines in Leishmania infection. , 2004, Current molecular medicine.

[35]  Y. Belkaid,et al.  Role for CD4+ CD25+ Regulatory T Cells in Reactivation of Persistent Leishmaniasis and Control of Concomitant Immunity , 2004, The Journal of experimental medicine.

[36]  Douglas E. Jones,et al.  The Immunology of Leishmania Infection and the Implications for Vaccine Development , 2004, Annals of the New York Academy of Sciences.

[37]  Jose L. Segovia-Juarez,et al.  Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. , 2004, Journal of theoretical biology.

[38]  N. Mitchison,et al.  Antigen-presenting cells do not discriminate between self and nonself , 2004, Immunogenetics.

[39]  Dave Higdon,et al.  Combining Field Data and Computer Simulations for Calibration and Prediction , 2005, SIAM J. Sci. Comput..

[40]  D. Mcmahon-Pratt,et al.  Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? , 2004, Immunological reviews.

[41]  Arturas Petronis,et al.  Phenotypic differences in genetically identical organisms: the epigenetic perspective. , 2005, Human molecular genetics.

[42]  Uta Berger,et al.  Pattern-Oriented Modeling of Agent-Based Complex Systems: Lessons from Ecology , 2005, Science.

[43]  David Higdon,et al.  Cosmic Calibration , 2006 .

[44]  B. Billack.  Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. , 2006, American journal of pharmaceutical education.

[45]  C. Beauchemin.  Probing the effects of the well-mixed assumption on viral infection dynamics. , 2005, Journal of theoretical biology.

[46]  William J. Welch,et al.  Screening the Input Variables to a Computer Model Via Analysis of Variance and Visualization , 2006 .

[47]  Y. Belkaid,et al.  Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens , 2006, The Journal of experimental medicine.

[48]  Steven G. Gilmour,et al.  Factor Screening via Supersaturated Designs , 2006 .

[49]  M. McConville,et al.  Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. J. Bayarri,et al.  Computer model validation with functional output , 2007, 0711.3271.

[51]  Rustom Antia,et al.  Understanding the Slow Depletion of Memory CD4+ T Cells in HIV Infection , 2007, PLoS medicine.

[52]  James O. Berger,et al.  A Framework for Validation of Computer Models , 2007, Technometrics.

[53]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[54]  Nicholas F. Polys,et al.  A virtual look at Epstein-Barr virus infection: simulation mechanism. , 2008, Journal of theoretical biology.